Global Lyme disease Treatment Market to hit $1,062,794.78 Thousand, Rising Cases of Chronic Lyme Disease among People Expected to Drive the Market Share, Says Research Dive

Growing cases of Lyme disease across the globe is thriving the global Lyme disease treatment market growth. The COVID-19 pandemic has negatively impacted the market. The Asia Pacific market is likely to lead the market in the near future

News provided by

Research Dive

Oct 20, 2021, 08:00 ET

NEW YORK, Oct. 20, 2021 /PRNewswire/ -- Research Dive has added a new report to its offering titled, "Lyme Disease Treatment Market by Treatment Type (Medication and Tick Removal), Administration Route (Oral, Injectable, and Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021-2028."

The Global Lyme Disease Treatment Market is expected to garner $1,062,794.78 thousand by 2028, growing at a CAGR of 7.50% from 2021 to 2028. The report delivers comprehensive insights into the current condition and future prospective of the industry by meticulously examining market drivers and restraints, opportunities, major segments, and regions.

Key Segment Findings of the Market:

The market is segmented based on treatment type, administration route, distribution channel, and region.

The medication treatment sub-segment of the treatment type segment is anticipated to hold maximum share of the market and collect a revenue of $807,760.80 thousand in the estimated period. This growth is mainly because of the increasing accessibility to numerous antibacterial drugs, for instance, doxycycline, for curing Lyme infection.

Download Your Exclusive PDF Sample Copy of the Lyme disease Treatment Market Report

The hospital pharmacies sub-segment of the distribution channel segment is anticipated to hold highest share of the market and garner $565,642.08 thousand in the estimated period. This growth is mainly owing to the increasing preference of Lyme patients for doctor's advice on their condition, as there is no sufficient knowledge among people about the disease. This fuels the sales of hospital pharmacy, thus driving the market growth.
The oral sub-segment of the administration route segment is anticipated to hold maximum share of the market and collect a revenue of $498,171.22 thousand in the estimated period. This growth is mainly because of the growing availability of many antibacterial medicines that can be taken through orally for the treatment of Lyme.
Among region, the Asia Pacific region market is projected to observe fastest growth and hit $150,916.86 thousand in the projected period. The growth of this region market is mostly owing to the increasing cases of tick borne infections or vector borne ailments in this region.

The Lyme Disease Treatment Market Share is expected to Grow Owing to Rising Number of Lyme Disease Patients – Trending Release by Research Dive

Market Dynamics

The key factor fueling the growth of the global Lyme disease treatment market is a significant rise in the occurrence of tick borne ailments across the world. In addition, increasing investments in R&D activities related to Lyme disease is expected to open doors to innovative opportunities for the market growth in the projected period. However, misinterpretations in the diagnosis of Lyme disease is projected to obstruct the market growth during the forecast period.

Impact of the COVID-19 Pandemic on the Lyme disease Treatment Market:

The COVID-19 pandemic has made a negative impact on the growth of the global Lyme disease treatment market in 2020. In the pandemic period, the Lyme disease treatment procedures have been put on hold; this is because hospitals and other healthcare centers are currently occupied with the COVID-19 patients. Additionally, Lyme patients are hesitating to visit hospitals owing the fear of getting infected with the COVID-19 virus. All these factors are deterring the growth of the market in the pandemic period.

Connect with Analyst to Reveal How COVID-19 Impacting on Lyme disease Treatment Market

Top 10 Key Players of Global Lyme disease Treatment Industry Are –

Chartwell Pharmaceuticals
Almirall, LLC.
Galaxo SmithKline Plc.
Novartis AG
Mayne Pharma
Sun Pharmaceuticals Industries, Inc.
Pfizer, Inc.
Lupin Pharmaceuticals, Inc.
Perrigo Company plc.
Orion Corporation

Inquire and Get Quick Access to Top Companies Development Strategies Summary Report

Numerous business strategies, such as acquisitions, mergers, R&D activities, new product developments, and much more, are implemented by these players to attain a strong position in the global market. For instance, in March 2021, the Columbia University's Vagelos College of Physicians and Surgeons launched a treatment center and clinical trials network for Lyme disease. The center is developed with an aim to provide proper treatment for patient of Lyme and related diseases.

Moreover, the report offers other key details of leading players such as business tactics, financial performance, and product/service range of these players along with Porter's five forces analysis and SWOT analysis.

Browse Adjacent Markets: Diagnostics and Biotech Market Research Reports & Consulting

Global Lyme disease Treatment Market: Segmentation

By Treatment Type

Medication
Tick Removal

By Administration Route

Oral
Injectable
Topical

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online

More about Lyme disease Treatment Market:

Related Trending Topics:

Allergy Diagnostics Market- The global allergy diagnostics market size is predicted to garner $10,472.92 million in the 2021–2028 timeframe, growing, at a healthy CAGR of 11.50%. – Request to Download Sample Report
Monogenetic Disease Therapy Market- Growing research and development activities are anticipated to drive the Global Monogenetic Disease Therapy Market – Request to Download Sample Report
Liver Disease Treatment Market - The global liver disease treatment market is anticipated to garner $32,028.5 million in the 2021–2028 period, at a noteworthy CAGR of 11.7%. – Request to Download Sample Report

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
Toll Free: 1-888-961-4454
E-mail: [email protected]
Website: https://www.researchdive.com
Blog: https://www.researchdive.com/blog/
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521